89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis
Clinical trial NCT06489652 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06489652
- Sponsor
- Jiangsu Renocell Biotech Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2025-05-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.